A brain tumor can strike anyone at any age, impacting a person’s very essence — everything from cognition and personality to movement and speech — if it’s fast-growing and aggressive. It can be the ...
A woman’s “tingly” and numb face turned out to be a brain tumor – after it was revealed by an MRI for an unrelated back problem. Amy Seager, 38, experienced numbness and tingling on the left side of ...
The deported mother of a U.S. citizen child who was recovering from a rare brain tumor recently found out she was denied a humanitarian request to return to the United States to continue her ...
BOSTON — A team at Children’s Hospital of Philadelphia (CHOP) led by Rebecca Ahrens-Niklas, MD, PhD, and Lindsey George, MD, has described a case of a brain tumor linked to a rare integration of adeno ...
It is a dogma in neuroscience that certain brain cells respond in the same way to the same thing. Specific neurons always fire, for example, when we see particular shapes and colours; other neurons ...
A hidden waste-removal pathway in the brain has finally been caught in action. Using cutting-edge MRI scans, researchers discovered that fluid flows along the middle meningeal artery in a slow, ...
Dunkin' fans: wake up and smell the free coffee. The coffee chain is giving away one million free coffees on May 19, it confirmed to USA TODAY. Dunkin' initially ignited rumors about a free coffee ...
Scientists have shown that brain connectivity patterns can predict mental functions across the entire brain. Each region has a unique “connectivity fingerprint” tied to its role in cognition, from ...
A so-called software supply chain attack, in which hackers corrupt a legitimate piece of software to hide their own malicious code, was once a relatively rare event but one that haunted the ...
A new study in Cell Reports Medicine from researchers at The University of Texas MD Anderson Cancer Center identified key features that may help predict which types of rare cancers are likely to ...
Chemotherapy drugs that target a common mutation in colorectal cancer rapidly lose efficacy in patients, leading to relapse. According to a new preclinical study by Weill Cornell Medicine and MD ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results